December 2022
1. THE LANCET
   Lecanemab for Alzheimer's disease: tempering hype and hope.
   Lancet. 2022;400:1899.
   

   >> Share

   
   April 2022
2. JAFFE S
   Medicare covers new Alzheimer's drug, but there is a catch.
   Lancet. 2022;399:1585.
   

   >> Share

   
   September 2021
3. SCHELTENS P
   Responding to responsive behaviour in Alzheimer's disease - Author's reply.
   Lancet. 2021;398:842.
   

   >> Share

   
   
4. O'NEILL D, Kennelly S
   Responding to responsive behaviour in Alzheimer's disease.
   Lancet. 2021;398:842.
   

   >> Share

   
   July 2021
5. JAFFE S
   US FDA defends approval of Alzheimer's disease drug.
   Lancet. 2021;398:12.
   

   >> Share

   
   March 2021
6. SCHELTENS P, De Strooper B, Kivipelto M, Holstege H, et al
   Alzheimer's disease.
   Lancet. 2021 Mar 2. pii: S0140-6736(20)32205.
   

   >> Share

   
   February 2021
7. SIVA N
   New global initiative to tackle Alzheimer's disease.
   Lancet. 2021;397:568-569.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share